Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Tsumura & Co ( (JP:4540) ).
Tsumura & Co. announced an additional monetary contribution to its performance-based stock compensation system for directors and executive officers. This move, involving a trust fund of 659 million yen, aims to secure funds for acquiring company shares, reflecting the company’s commitment to aligning management incentives with shareholder interests.
The most recent analyst rating on (JP:4540) stock is a Buy with a Yen4044.00 price target. To see the full list of analyst forecasts on Tsumura & Co stock, see the JP:4540 Stock Forecast page.
More about Tsumura & Co
Tsumura & Co. operates in the pharmaceutical industry, focusing on the production and distribution of traditional Japanese Kampo medicines. The company is listed on the Tokyo Stock Exchange Prime Market and is known for its dedication to integrating traditional herbal medicine with modern scientific research.
Average Trading Volume: 539,561
Technical Sentiment Signal: Hold
Current Market Cap: Yen278.2B
Find detailed analytics on 4540 stock on TipRanks’ Stock Analysis page.